Comparison of the results of subthreshold micropulse laser coagulation in patients with various forms of macular degeneration
Author: Mariia Melikhova (Russian Federation)
Co-authors: Marina Gatcu
Purpose
Evaluation of the effectiveness of micropulse subthreshold laser coagulation (SML) in 3 groups: sclerogenic macular degeneration (SMD), acute and chronic central serous chorioretinopathy (CSR)
Setting/Venue
S. Fyodorov "Eye Microsurgery" Federal State Institution, St. Petersburg Branch
Methods
SML was performed in 3 groups of patients. Group 1 - 15 patients with SMD aged 28 to 63 years, the median age was 55.0 (40; 62) years. Group 2 with acute CSR included 16 patients aged 21 to 51 years, the median age was 37.0 (32; 42.5) years. Group 3 - a chronic form of CSR consisted of 15 people aged from 26 to 56 years, the median age was 43.0 (40; 51). In group 1, women predominated (93%), in groups 2 and 3, men (94% and 80%, respectively). SML was performed with a diode laser (810 nm). In the subthreshold mode, a 10% microimpulse was used, 2-3 sessions were performed with an interval of 2-4 months. The observation period was 6-12 months. The treatment was carried out according to the method of a dense "lattice" with an additional effect on the supposed points of dye leakage. The criterion of efficiency was the complete disappearance of the liquid. In the study, patient data were recorded at 5 time points, each subsequent point was compared with the baseline.
Results
In group 1 of patients, serous retinal detachment (SRD) completely adhered in 7 out of 15 people (46.7%), there were no relapses during the year of follow-up. In group 2, the treatment effect was achieved in 11 out of 16 people (68.8%), 3 relapses of SRD. In group 3 with chronic CSR, complete regression of SRD was achieved in 10 out of 15 people (66.7%) with 1 recurrence of SRD. Significant dynamics of BCVA and retinal thickness in the central zone were observed only in the group with acute CSR
Conlusions
SML accelerates the resorption of subretinal fluid as efficiently as possible in patients with acute CSR. In the other two groups, this method of treatment cannot be considered completely satisfactory due to the very slow rate of regression of SRD and the absence of a significant effect on visual acuity